Impacto de diferentes planos de alimentación pos-desleche en terneras Holstein de reemplazo

Se realizó un experimento para evaluar el efecto del plano de alimentación postdesleche sobre el comportamiento animal, el crecimiento y el desarrollo corporal, y la llegada a la pubertad en bovinos. Se usaron 40 vaquillonas Holstein deslechadas, con 77,7 días de vida y 77,5 kg de peso vivo en promedio, que fueron asignadas a 2 tratamientos, correspondientes a 2 planos de alimentación para lograr 2 ganancias de peso vivo teóricas distintas: 700-800 (TMEDIA) o 1000-1100 (TALTA) g/día. Para ello, los animales se alimentaron con una misma ración totalmente mezclada, que fue ofrecida en distinta cantidad de forma de lograr las ganancias buscadas. El diseño usado fue de corrales, con 5 repeticiones de 4 animales cada una por tratamiento. Los tratamientos se aplicaron durante 120 días consecutivos, y durante este período se realizaron mediciones de comportamiento, consumo de nutrientes, peso vivo y otras medidas morfológicas, y se determinaron las concentraciones sanguíneas de IGF-I, insulina y glucosa. Al finalizar la aplicación de los tratamientos todos los animales se manejaron como un único grupo para evaluar los efectos residuales durante 150 días, y se determinó la entrada a la pubertad mediante ultrasonografía trans-rectal. Las vaquillonas TALTA tuvieron una mayor ganancia de peso (799 vs. 597 g/día) y mediciones de variables morfológicas como altura a la cruz y ancho entre caderas que las TMEDIA, y una mayor concentración sanguínea de IGF-I, aunque no de insulina o glucosa, durante el período de aplicación de los tratamientos. Sin embargo, no se evidenciaron diferencias en las tasas de ganancia o en la concentración de IGF-I durante el período de evaluación residual. Si bien no hubo diferencias en la proporción de vaquillonas que llegaron a la pubertad, la velocidad con que las vaquillonas TMEDIA llegaron a la pubertad fue más rápida respecto a las TALTA. Se concluye que aumentar el nivel de alimentación de vaquillonas luego del desleche tuvo efectos marcados sobre el crecimiento y el desarrollo corporal en el corto plazo, pero efectos más moderados en el mediano plazo, una vez que todos los animales se manejaron de la misma manera

Global variations in diabetes mellitus based on fasting glucose and haemogloblin A1c

Fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) are both used to diagnose diabetes, but may identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening had elevated FPG, HbA1c, or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardised proportion of diabetes that was previously undiagnosed, and detected in survey screening, ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the agestandardised proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global gap in diabetes diagnosis and surveillance.peer-reviewe

Post-weaning feeding levels on feeding behavior, growth and development in Holstein dairy heifers

<div><p>ABSTRACT: To study the effect of post-weaning feeding levels on the growth of dairy heifers, 40 animals with 77.7 ± 8.1 days of age and 77.5 ± 9.2kg of body weight were grouped in 10 pens, and each pen was randomly assigned to one of the following treatments for 120 days: feeding level to achieve a body weight gain of 600 (TMEDIUM) or 800 (THIGH) g/day based on a total mixed ration. After this period all heifers were managed as a single group for 150 days. Nutrient intake, behavior, body weight and other morphological measures were recorded in each animal. As a result of the experimental design THIGH heifers had a higher nutrient intake than TMEDIUM heifers, which was reflected in a higher daily weight gain, withers height, heart girth and hip width. However, treatments had no effect on these traits during the residual period.</p></div

Diminishing benefits of urban living for children and adolescents’ growth and development

Optimal growth and development in childhood and adolescence is crucial for lifelong health and well-being1–6. Here we used data from 2,325 population-based studies, with measurements of height and weight from 71 million participants, to report the height and body-mass index (BMI) of children and adolescents aged 5–19 years on the basis of rural and urban place of residence in 200 countries and territories from 1990 to 2020. In 1990, children and adolescents residing in cities were taller than their rural counterparts in all but a few high-income countries. By 2020, the urban height advantage became smaller in most countries, and in many high-income western countries it reversed into a small urban-based disadvantage. The exception was for boys in most countries in sub-Saharan Africa and in some countries in Oceania, south Asia and the region of central Asia, Middle East and north Africa. In these countries, successive cohorts of boys from rural places either did not gain height or possibly became shorter, and hence fell further behind their urban peers. The difference between the age-standardized mean BMI of children in urban and rural areas was <1.1 kg m–2 in the vast majority of countries. Within this small range, BMI increased slightly more in cities than in rural areas, except in south Asia, sub-Saharan Africa and some countries in central and eastern Europe. Our results show that in much of the world, the growth and developmental advantages of living in cities have diminished in the twenty-first century, whereas in much of sub-Saharan Africa they have amplified

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

International audienceAbstract Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose diabetes, but these measurements can identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening, had elevated FPG, HbA1c or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardized proportion who had elevated levels of both FPG and HbA1c was 29–39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c was more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global shortfall in diabetes diagnosis and surveillance

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

: Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose diabetes, but these measurements can identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening, had elevated FPG, HbA1c or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardized proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c was more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global shortfall in diabetes diagnosis and surveillance